tiprankstipranks
Trending News
More News >
Beijing Tong Ren Tang Chinese Medicine Co (HK:3613)
:3613
Advertisement

Beijing Tong Ren Tang Chinese Medicine Co (3613) Price & Analysis

Compare
1 Followers

3613 Stock Chart & Stats

HK$8.82
-HK$0.07(-0.87%)
At close: 4:00 PM EST
HK$8.82
-HK$0.07(-0.87%)

Beijing Tong Ren Tang Chinese Medicine Co News

3613 FAQ

What was Beijing Tong Ren Tang Chinese Medicine Co’s price range in the past 12 months?
Beijing Tong Ren Tang Chinese Medicine Co lowest stock price was HK$7.83 and its highest was HK$9.72 in the past 12 months.
    What is Beijing Tong Ren Tang Chinese Medicine Co’s market cap?
    Beijing Tong Ren Tang Chinese Medicine Co’s market cap is HK$7.32B.
      When is Beijing Tong Ren Tang Chinese Medicine Co’s upcoming earnings report date?
      Beijing Tong Ren Tang Chinese Medicine Co’s upcoming earnings report date is Mar 26, 2026 which is in 137 days.
        How were Beijing Tong Ren Tang Chinese Medicine Co’s earnings last quarter?
        Beijing Tong Ren Tang Chinese Medicine Co released its earnings results on Aug 22, 2025. The company reported HK$0.28 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.28.
          Is Beijing Tong Ren Tang Chinese Medicine Co overvalued?
          According to Wall Street analysts Beijing Tong Ren Tang Chinese Medicine Co’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Beijing Tong Ren Tang Chinese Medicine Co pay dividends?
            Beijing Tong Ren Tang Chinese Medicine Co pays a Annually dividend of HK$0.35 which represents an annual dividend yield of 3.99%. See more information on Beijing Tong Ren Tang Chinese Medicine Co dividends here
              What is Beijing Tong Ren Tang Chinese Medicine Co’s EPS estimate?
              Beijing Tong Ren Tang Chinese Medicine Co’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Beijing Tong Ren Tang Chinese Medicine Co have?
              Beijing Tong Ren Tang Chinese Medicine Co has 837,100,000 shares outstanding.
                What happened to Beijing Tong Ren Tang Chinese Medicine Co’s price movement after its last earnings report?
                Beijing Tong Ren Tang Chinese Medicine Co reported an EPS of HK$0.28 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.184%.
                  Which hedge fund is a major shareholder of Beijing Tong Ren Tang Chinese Medicine Co?
                  Currently, no hedge funds are holding shares in HK:3613

                  Company Description

                  Beijing Tong Ren Tang Chinese Medicine Co

                  Beijing Tong Ren Tang Chinese Medicine Co (3613) is a renowned company specializing in the production and distribution of traditional Chinese medicine (TCM) products. With a rich heritage dating back to 1669, the company is a leader in the TCM industry, offering a wide range of herbal medicines, health supplements, and wellness products. It operates across various sectors, including retail, wholesale, and healthcare services, catering to a global market with a strong presence in Asia, Europe, and the Americas.

                  Beijing Tong Ren Tang Chinese Medicine Co (3613) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  China Traditional Chinese Medicine Holdings Co
                  Tong Ren Tang Technologies Co
                  CStone Pharmaceuticals
                  China Shineway Pharmaceutical Group Limited
                  Golden Throat Holdings Group Co Ltd

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis